Recon Strategy
Contact

Insights

Fifteen+ years of
healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

ESSENTIAL READING

  • Biopharma, Payers, Institutional

Outcomes Based Arrangements in Biopharma

Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisions based on early, incomplete data when it comes to durability, real-world effectiveness, and cost-effectiveness – all while bearing costs that can exceed $1 million per patient.
  • Biopharma

A few thoughts about navigating biopharma macro scenarios

Planning biopharma strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While historically these scenarios have revolved around targeted issues, the current challengescall for a more expansive - and likely more difficult - set of questions to be asked.
  • Biopharma, Payers, Providers, Medtech, Digital

Why the Best AI Won’t Win in Healthcare

As advanced AI becomes widely accessible, healthcare companies can no longer rely on superior technology alone for lasting advantage. Instead, they need a coherent AI strategy built around five interconnected choices. Harvard Business Review article.
Sector
All
NEJM opinion

NEJM Highlights December 2015: providing effective healthcare is hard and expensive – but ineffective care can be even more expensive – and defining what expensive means in healthcare is hard

  • NEJM
A new focus on the diagnostic reliability of clinicians Two perspectiv…

Read more

Emails substituting for visits: Evidence points to “yes” but providers need to answer a lot of emails to replace a single visit

  • Providers , 
  • Digital , 
Earlier this month, researchers released a study of patient-initiated …

Read more

Maxwell Health and Agile Healthcare Strategy

  • Digital , 
Maxwell Health LLC is a rapidly growing company that offers a platform…

Read more

Ohio’s Mercy-Summa alliance grows contracting teeth

  • Payers , 
  • Providers
Mercy Health – the largest system in Ohio – has recently formed a Clin…

Read more

NEJM Highlights November 2015: systems biology, RSV progress, a first in diabetes, hypertension goals, the case of Maryland

  • NEJM
Systems biology finally gets real: an unexpected use for a diabetes dr…

Read more

NEJM Highlights October 2015: what to do, how to do it, and to whom

  • NEJM
What are annual physicals for? Annual physicals are costly (~$10 billi…

Read more

Convenience care, telemedicine and breaking down barriers to geographic competition – a speculation

  • Providers , 
  • Digital
A few problems Geographic barriers to the entry have long protected pr…

Read more

Working paper: the coming age of algorithmic medicine

  • Payers , 
  • Providers , 
  • Digital , 
Summary In this working paper, we develop the following thesis. In the…

Read more

The Ochsner Health Network: has Ochsner gone “a hospital too far”?

  • Providers
Over eight months between October 2014 and June of this year, Ochsner …

Read more

SELECTED ENGAGEMENTS

Insight, put to work

Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.

  • Institutional

Strategy for Statewide Health Information Exchange

A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable

HIE, Health IT,

  • Medtech, Early Stage

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

  • Institutional

University Trials

Large university wanting to dramatically increase its clinical research footprint

Keep up with Recon Strategy Insights
Get an email each time we publish a new article